1. Factors associated with myopia in Korean children: Korea National Health and nutrition examination survey 2016-2017 (KNHANES VII). Kim H, Seo JS, Yoo WS, Kim GN, Kim RB, Chae JE, Chung I, Seo SW, Kim SJ.BMC Ophthalmol. 2020 Jan 20;20(1):31. doi: 10.1186/s12886-020-1316-6. 2. Prevalence and risk factors of myopia in adult Korean population: Korea national health and nutrition examination survey 2013-2014 (KNHANES VI). Han SB, Jang J, Yang HK, Hwang JM, Park SK.PLoS One. 2019 Jan 24;14(1):e0211204. doi: 10.1371/journal.pone.0211204. eCollection 2019. 3. Myopia Growth Chart Based on a Population-Based Survey (KNHANES IV-V): A Novel Prediction Model of Myopic Progression in Childhood. Kim DH, Lim HT. 4. Prevalence and risk factors for myopia in a rural Korean population. Lee JH, Jee D, Kwon JW, Lee WK.Invest Ophthalmol Vis Sci. 2013 Aug 13;54(8):5466-71. doi: 10.1167/iovs.13-12478. 5. Prevalence of myopia and its association with body stature and educational level in 19-year-old male conscripts in seoul, South Korea. Jung SK, Lee JH, Kakizaki H, Jee D.Invest Ophthalmol Vis Sci. 2012 Aug 15;53(9):5579-83. doi: 10.1167/iovs.12-10106. 6. Factors associated with myopia in 19-year-old adult men in Korea between 2014 and 2020. Gwon SH, Lee DC. Sci Rep. 2023 Jul 18;13(1):11581. doi: 10.1038/s41598-023-38569-w. 7. The high prevalence of myopia in Korean children with influence of parental refractive errors: The 2008-2012 Korean National Health and Nutrition Examination Survey. Lim DH, Han J, Chung TY, Kang S, Yim HW; Epidemiologic Survey Committee of the Korean Ophthalmologic Society.PLoS One. 2018 Nov 26;13(11):e0207690. doi: 10.1371/journal.pone.0207690. eCollection 2018. 8. Risk Factors for High Myopia in Koreans: The Korea National Health and Nutrition Examination Survey. Hwang HS, Chun MY, Kim JS, Oh B, Yoo SH, Cho BJ.Curr Eye Res. 2018 Aug;43(8):1052-1060. doi: 10.1080/02713683.2018.1472286. Epub 2018 May 10.PMID: 29718719 9. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, Tan D.Ophthalmology. 2012 Feb;119(2):347-54. doi: 10.1016/j.ophtha.2011.07.031. Epub 2011 Oct 2. 10. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Tong L, Huang XL, Koh AL, Zhang X, Tan DT, Chua WH.Ophthalmology. 2009 Mar;116(3):572-9. doi: 10.1016/j.ophtha.2008.10.020. Epub 2009 Jan 22.PMID: 19167081 Clinical Trial. 11. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Chia A, Chua WH, Wen L, Fong A, Goon YY, Tan D.Am J Ophthalmol. 2014 Feb;157(2):451-457.e1. doi: 10.1016/j.ajo.2013.09.020. Epub 2013 Dec 4. 12. Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis. Ha A, Kim SJ, Shim SR, Kim YK, Jung JH.Ophthalmology. 2022 Mar;129(3):322-333. doi: 10.1016/j.ophtha.2021.10.016. Epub 2021 Oct 22. 13. Comparison of ocular component growth curves among refractive error groups in children. Jones LA, Mitchell GL, Mutti DO, Hayes JR, Moeschberger ML, Zadnik K.Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2317-27. doi: 10.1167/iovs.04-0945. 14. Atropine for the treatment of childhood myopia. Chua WH, Balakrishnan V, Chan YH, Tong L, Ling Y, Quah BL, Tan D.Ophthalmology. 2006 Dec;113(12):2285-91. doi: 10.1016/j.ophtha.2006.05.062. Epub 2006 Sep 25.PMID: 16996612 Clinical Trial. 15, Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Chia A, et al. Ophthalmology. 2016. PMID: 26271839 Clinical Trial. 16. Five-Year Clinical Trial of Low-concentration Atropine for Myopia Progression (LAMP) Study: Phase 4 Report. Zhang XJ, et al. Ophthalmology. 2024. PMID: 38494130 17. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Cho P, et al. Invest Ophthalmol Vis Sci. 2012. PMID: 22969068 Clinical Trial. 18. Orthokeratology to control myopia progression: a meta-analysis. Sun Y, et al. PLoS One. 2015. PMID: 25855979 Free PMC article. 19. Long-Term Efficacy of Orthokeratology to Control Myopia Progression. Lv H, et al. Eye Contact Lens. 2023. PMID: 37471255 Free PMC article. 20. Undercorrection of myopia enhances rather than inhibits myopia progression. Chung K, Mohidin N, O'Leary DJ.Vision Res. 2002 Oct;42(22):2555-9. doi: 10.1016/s0042-6989(02)00258-4. 21. The possible effect of undercorrection on myopic progression in children. Adler D, Millodot M.Clin Exp Optom. 2006 Sep;89(5):315-21. doi: 10.1111/j.1444-0938.2006.00055.x.PMID: 16907670 Free article. Clinical Trial. 22. Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment. Domsa P, Bankó ÉM, Körtvélyes J, Meigen C, Széchey R, Lantos K, Nagy ZZ, Csutak A.BMJ Open Ophthalmol. 2024 Mar 7;9(1):e001499. doi: 10.1136/bmjophth-2023-001499. 23. Under-correction or full correction of myopia? A meta-analysis. Yazdani N, Sadeghi R, Ehsaei A, Taghipour A, Hasanzadeh S, Zarifmahmoudi L, Heravian Shandiz J.J Optom. 2021 Jan-Mar;14(1):11-19. doi: 10.1016/j.optom.2020.04.003. Epub 2020 Jun 2.PMID: 32507615 Free PMC article. Review. 24. Under-correction of human myopia--is it myopigenic?: a retrospective analysis of clinical refraction data. Vasudevan B, Esposito C, Peterson C, Coronado C, Ciuffreda KJ.J Optom. 2014 Jul-Sep;7(3):147-52. doi: 10.1016/j.optom.2013.12.007. Epub 2014 May 10.PMID: 25000870 Free PMC article. 25. Effect of uncorrection versus full correction on myopia progression in 12-year-old children. Sun YY, Li SM, Li SY, Kang MT, Liu LR, Meng B, Zhang FJ, Millodot M, Wang N.Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):189-195. doi: 10.1007/s00417-016-3529-1. Epub 2016 Oct 29. 26. Full correction and Undercorrection of Myopia Evaluation Trial: design and baseline data of a randomized, controlled, double-blind trial. Li SM, Li SY, Liu LR, Guo JY, Chen W, Wang NL, Millodot M.Clin Exp Ophthalmol. 2013 May-Jun;41(4):329-38. doi: 10.1111/j.1442-9071.2012.02884.x. Epub 2012 Dec 27. Invest Ophthalmol Vis Sci 2014 Aug 12;55(10):6679-85. doi: 10.1167/iovs.14-14801. Quantitative analysis of functional changes caused by pinhole glasses Won Soo Kim 1, In Ki Park 2, Yeoun Sook Chun 1 28. Effect of Time Spent Outdoors at School on the Development of Myopia Among Children in China: A Randomized Clinical Trial. He M, Xiang F, Zeng Y, Mai J, Chen Q, Zhang J, Smith W, Rose K, Morgan IG.JAMA. 2015 Sep 15;314(11):1142-8. doi: 10.1001/jama.2015.10803. 29. Effect of School-Based Family Health Education via Social Media on Children's Myopia and Parents' Awareness: A Randomized Clinical Trial. Li Q, Guo L, Zhang J, Zhao F, Hu Y, Guo Y, Du X, Zhang S, Yang X, Lu C.JAMA Ophthalmol. 2021 Nov 1;139(11):1165-1172. doi: 10.1001/jamaophthalmol.2021.3695. 30. Time Outdoors in Reducing Myopia: A School-Based Cluster Randomized Trial with Objective Monitoring of Outdoor Time and Light Intensity. He X, Sankaridurg P, Wang J, Chen J, Naduvilath T, He M, Zhu Z, Li W, Morgan IG, Xiong S, Zhu J, Zou H, Rose KA, Zhang B, Weng R, Resnikoff S, Xu X.Ophthalmology. 2022 Nov;129(11):1245-1254. doi: 10.1016/j.ophtha.2022.06.024. Epub 2022 Jun 30. 31. Time spent outdoors as an intervention for myopia prevention and control in children: an overview of systematic reviews. Dhakal R, Shah R, Huntjens B, Verkicharla PK, Lawrenson JG.Ophthalmic Physiol Opt. 2022 May;42(3):545-558. doi: 10.1111/opo.12945. Epub 2022 Jan 24. 32. The epidemics of myopia: Aetiology and prevention. Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, Rose KA.Prog Retin Eye Res. 2018 Jan;62:134-149. doi: 10.1016/j.preteyeres.2017.09.004. Epub 2017 Sep 23.PMID: 28951126 Review. 33. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report. Yam JC, Li FF, Zhang X, Tang SM, Yip BHK, Kam KW, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP.Ophthalmology. 2020 Jul;127(7):910-919. doi: 10.1016/j.ophtha.2019.12.011. Epub 2019 Dec 21.PMID: 32019700 Clinical Trial. 34. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP.Ophthalmology. 2019 Jan;126(1):113-124. doi: 10.1016/j.ophtha.2018.05.029. Epub 2018 Jul 6. 35. Full-field electroretinogram findings in children in the atropine treatment for myopia (ATOM2) study. Chia A, Li W, Tan D, Luu CD.Doc Ophthalmol. 2013 Jun;126(3):177-86. doi: 10.1007/s10633-012-9372-8. Epub 2013 Jan 5. 36. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S.Ophthalmology. 2016 May;123(5):1036-42. doi: 10.1016/j.ophtha.2016.01.006. Epub 2016 Feb 11.